SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Clinical trials for SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for head and neck cancer: experimental combo targets tough tumors
Disease control Not yet recruitingThis phase 3 trial tests two experimental treatments—ivonescimab alone or with ligufalimab—against the standard drug pembrolizumab for people with advanced head and neck cancer that has come back or spread. About 780 adults with PD-L1-positive tumors will take part. The main goal…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Phase: PHASE3 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
Diagnosis Not yet recruitingThis early-phase trial tests whether a fluorescent dye attached to an immunotherapy drug can help surgeons see head and neck cancer cells during surgery. About 40 adults with head and neck cancer will receive the dye before their standard surgery. The main goal is to check if the…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated May 15, 2026 11:55 UTC